[1]
“Immunological and Clinical Aspects Determining the Risk of Recurrence in Patients with Luminal Subtype of Breast Cancer Stages I–III”, Вопр. онкол., vol. 71, no. 3, p. OF-2271, Jun. 2025, doi: 10.37469/0507-3758-2025-71-3-OF-2271.